- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT06238323
Lafiya HIV Self-testing Study Protocol
June 9, 2026 updated by: Gamji Rabiu Abu-Ba'are, University of Rochester
Adaptation and Feasibility of Many Men Many Voices (3MV), an HIV Prevention Intervention to Reduce Intersectional Stigma and Increase HIVST Among YSMM Residing in Ghanaian Slums - A Clustered Pre-post Pilot Trial Protocol
The study aims to address low testing and related issues such as stigma, low-risk perception, and concerns about confidentiality affecting testing.
To overcome these challenges, the study proposes to adapt the Many Men Many Voices (3MV) into a modified version called LAFIYA to tackle intersectional stigma and improve HIVST among young sexual minority men in Ghana.
Study Overview
Status
Active, not recruiting
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Estimated)
40
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Accra, Ghana
- University of Ghana
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
Accepts Healthy Volunteers
Yes
Description
Inclusion Criteria:
- YSMM: To be eligible to participate in the interview, the person must be between 18 to 25 years old, have no experience using unassisted HIVST kits, do not know their HIV status or tested negative, currently identifies as cis-gender man, and have had sex with another man within six months before engaging with the recruitment team and must reside within a slum community in the Greater Accra Metropolitan area.
- Providers: To be eligible to participate in the interview, the person must have experience providing sexual health services such as HIV testing, counseling, and linkage to prevention and care services for at least one year. Must reside within the Greater Accra Metropolitan area and have worked with YSMM on HIV prevention and care.
Exclusion Criteria:
- YSMM: Those who fall under 18 years or above 25 years will be excluded from the study. YSMM who have experience with unassisted HIVST kits, know their HIV status, or tested positive for HIV will be excluded from the study. YSMM who do not identify as cis-gender man and have not had sex with another man within six months before engaging with the recruitment team will be excluded from the study. YSMM who do not reside within a slum community in the Greater Accra Metropolitan area will be excluded from the study.
- Providers: Persons who do not have experience providing services such as HIV testing, counseling, and linkage to prevention and care services for at least one year will be excluded from the study. Providers not residing within the Greater Accra Metropolitan area and have not worked with YSMM on HIV prevention and care will be excluded.
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: All participants
Participants will be young sexual minority men (YSMM) and providers from healthcare institutions working with YSMM.
|
LAFIYA will be a modified version of the Many Men Many Voices (3MV) targeted at addressing reducing stigma and increasing HIV self-testing uptake among young sexual minority men.
LAFIYA will be developed into a comprehensive intervention manual for a large-scale trial using the ADAPTT-IT framework.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in percentage of participants that reported the intervention as acceptable
Time Frame: Baseline to 3 months
|
Participants will be provided with a survey that inquires if HIVST meets their approval, meets their needs, and if they welcome the use of HIVST.
Participants will answer yes or no, and reported is the change in the percentage of participants that answered yes to each question.
|
Baseline to 3 months
|
|
Change in percentage of participants that reported the intervention as appropriate
Time Frame: Baseline to 3 months
|
Participants will be provided with a survey that inquires if HIVST seems reasonable, if HIVST seems like a good match, and if HIVST seems applicable.
Participants will answer yes or no, and reported is the change in the percentage of participants that answered yes to each question.
|
Baseline to 3 months
|
|
Change in percentage of participants that reported the intervention as feasible.
Time Frame: Baseline to 3 months
|
Participants will be provided with a survey that inquires if HIVST seems easy to use, if HIVST seems challenging, and if HIVST seems practical.
Participants will answer yes or no, and reported is the change in the percentage of participants that answered yes to each question.
|
Baseline to 3 months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Change in the number of HIV tests
Time Frame: Baseline to 3 months
|
We are going to collect the total number of HIV tests performed by all participants and report the mean change in number.
|
Baseline to 3 months
|
|
Mean change in the Basic Needs Satisfaction Scale.
Time Frame: Baseline to 3 months
|
The Basic Needs Satisfaction scale is a 9 question scale that asks participants general questions about experiences of feeling free within their community while identifying as YSMM.
The outcome measure will analyze changes in average scores over time.
The Basic Needs Satisfaction Scale is scored on a scale ranging from 1 to 10, where 1 represents the lowest possible level of basic needs satisfaction, and 10 represents the highest
|
Baseline to 3 months
|
|
Percentage of participants to report resilience/bouncing back after hard times.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 6 question survey that inquires into a percentage change in their level of resilience.
Each question inquires into their ability to bounce back or cope with challenges, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Percentage of participants that reported enacted stigma.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the rate at which they experienced unfair treatment by others.
Each question will inquire into experiences of unfair treatment, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated for an overall percent score.
|
Baseline to 3 months
|
|
Percentage of participants that reported vicarious stigma.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the percentage rate at which they have heard stories about other YSMM stigma experiences.
Each question inquires whether they have heard stories of other YSMM experiencing stigma, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Percentage of participants that reported perceived stigma.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the level of agreement or disagreement on perceived stigma.
Each question inquires whether they agree or disagree with perceived stigma, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Percentage in participants that reported internalized stigma.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the percentage change in internalized stigma.
Each question inquires into their experience of internalized stigma, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Percentage of participants that reported stigma for involving in same sex relations.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the frequency at which they encounter stigma from engaging in same-sex relations.
Each question inquires into their experiences of stigma from engaging in same-sex relationships, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Percentage of participants that reported stigma from being gender non-conforming.
Time Frame: Baseline to 3 months
|
Participants will be provided with a 10 question survey that inquires into the frequency at which they encounter stigma due to their feminine mannerisms.
Each question inquires into their experiences of stigma from being gender non-conforming, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
|
Healthcare climate
Time Frame: Baseline to 3 months
|
Participants will be provided with a 6 question survey that inquires into the frequency at which they encounter negative health provider attitudes.
Each question inquires into their experiences when dealing with health providers, with responses categorized as "yes" or "no."
The survey results are then analyzed by calculating the percentage of participants who responded affirmatively (yes) to each question.
The average percentage across all questions is calculated to arrive at an overall percent score.
|
Baseline to 3 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
February 1, 2025
Primary Completion (Estimated)
March 30, 2027
Study Completion (Estimated)
March 30, 2027
Study Registration Dates
First Submitted
January 25, 2024
First Submitted That Met QC Criteria
January 25, 2024
First Posted (Actual)
February 2, 2024
Study Record Updates
Last Update Posted (Actual)
June 11, 2026
Last Update Submitted That Met QC Criteria
June 9, 2026
Last Verified
June 1, 2026
More Information
Terms related to this study
Other Study ID Numbers
- STUDY00008385
- R01TW012671 (U.S. NIH Grant/Contract)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on HIV Prevention and Care
-
Duke UniversityGilead SciencesRecruitingHIV Prevention | HIV Pre-exposure Prophylaxis | HIV Prevention Program | HIV Prevention and Care | HIV Pre-exposure Prophylaxis UseUnited States
-
Public Health Foundation Enterprises, Inc.TerminatedAdherence | HIV Pre-exposure Prophylaxis | Mobile Health Technology (mHealth) | HIV Prevention and Care | Doxycycline STI PEPUnited States
-
University of RochesterYale University; National Institute of Nursing Research (NINR); University of...Withdrawn
-
Johns Hopkins UniversityNational Institute of Mental Health (NIMH); University of MichiganActive, not recruitingPrEP | HIV Prevention | Primary CareUnited States
-
University of KwaZuluUniversity of California, San Francisco; Centers for Disease Control and Prevention and other collaboratorsCompletedEffectiveness of an HIV-adapted IMCI Training and Supervision Programme for Community Health WorkersInfant Feeding Practices | Prevention of Mother-to-child Transmission of HIV | Antenatal Health Care Utilization | Postnatal Health Care UtilizationSouth Africa
-
Taipei Veterans General Hospital, TaiwanCompletedTreatment | Prevention | Supportive CareTaiwan
-
Universität des SaarlandesDIKOM ConsortiumNot yet recruitingNursing Home Care | Hospitalisation PreventionGermany
-
University of Alabama at BirminghamMassachusetts General HospitalNot yet recruitingHIV Prevention | HIV Risk | Sexual and Reproductive HealthUnited States
-
University of California, Los AngelesRecruitingHIV PreventionUnited States
-
Institute of HIV Research and Innovation Foundation...National Institutes of Health (NIH)RecruitingHIV Prevention | PrEP Adherence | HIV Related StigmaThailand
Clinical Trials on LAFIYA
-
University of RochesterYale University; National Institute of Nursing Research (NINR); University of...Withdrawn